Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer
Seminars in Radiation Oncology, 2017The rising incidence of early-stage lung cancer, particularly in medically inoperable patients, is anticipated because of the implementation of early detection strategies and population aging in the United States and worldwide. This mandates the development of noninvasive curative treatment approaches for this disease.
Jennifer L, Shah, Billy W, Loo
openaire +2 more sources
Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer
Surgical Oncology Clinics of North America, 2016The treatment paradigm for early stage lung cancer and oligometastatic disease to the lung is rapidly changing. Ablative therapies, especially stereotactic body radiation therapy, are challenging the surgical gold standard and have the potential to be the standard for operable patients with early stage lung cancer who are high risk due to co ...
Ghulam, Abbas +2 more
openaire +2 more sources
Stereotactic Ablative Radiotherapy Uncertainties: Delineation, Setup and Motion
Seminars in Radiation Oncology, 2018Stereotactic ablative radiotherapy (SAbR), also known as stereotactic body radiation therapy, is biologically distinct from conventionally fractionated radiotherapy in that it is ablative, causing functional incapacitation of targeted tissue including margins added to avoid errors.
Ming, Yang, Robert, Timmerman
openaire +2 more sources
Stereotactic Ablative Radiotherapy for ‘Oligometastases’: a Treatment in Search of Evidence
Clinical Oncology, 2016For over 30 years, metastasectomy has been seen as standard practice for patients with soft tissue sarcoma or osteosarcoma and lung metastases [1]. For 10 years, liver metastases have been resected from patients with colorectal cancer and metastasectomy has become one of the more frequently performed liver operations in the UK [2e4].
F, Macbeth, T, Treasure
openaire +2 more sources
Functional Outcomes of Stereotactic Ablative Radiotherapy: There Is Room for Improvement
European Urology OncologyN.A.
Bertolo, Riccardo +2 more
openaire +2 more sources
Radiobiology of Stereotactic Body Radiation Therapy/Stereotactic Ablative Radiotherapy
2012Stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR) is rapidly being adopted as a treatment modality, particularly for liver and lung tumors, and because of the dramatic improvements in tumor control, the use of SBRT is being directed toward other anatomical sites.
Michael D. Story +2 more
openaire +1 more source
Cardiac Stereotactic Ablative Radiotherapy – a Multidisciplinary Approach
Clinical Oncology, 2023openaire +2 more sources
Stereotactic ablative radiotherapy for primary kidney cancer
The Lancet OncologyPriyank, Bhargava +2 more
openaire +6 more sources
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation
Radiotherapy and Oncology, 2021David Pasquier, Sophia Kamran
exaly
The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma
European Urology, 2022Lawrentschuk N +2 more
exaly